Write a reviewFor vendors
♡
Home / Investors / Startups / DiscGenics

DiscGenics

Regenerative Cell Therapy for Chronic Back Pain.
discgenics.com ↗LinkedInX / Twitter

About DiscGenics

Clinical stage biotechnology company developing cell-based regenerative therapies that alleviate pain and restore function in patients with degenerative diseases of the spine.

Industries

BioTechHealthcareLife Science

Investors in DiscGenics (5)

Mitsubishi UFJ Capital

Venture Fund · Tokyo, Japan · Founded 1974
SeedSeries ASeries BSeries CPropTechBioTechHealthcareLife Science+6
444Investments
68Exits

Eagle Venture Fund

Venture Fund
Series CBioTechHealthcareLife Science
6Investments
0Exits

Medical Incubator Japan

Venture Fund
SeedSeries ASeries BSeries CBioTechHealthcareLife Science
4Investments
—Exits

CareNet

Tokyo, Japan · Founded 1996
BioTechHealthcareLife Science
3Investments
—Exits

Najeeb Thomas

Angel Investor
BioTechHealthcareLife Science
—Investments
—Exits